ADIL:Adial Pharmaceuticals Inc Snapshot | Charting | News | Options
$1.70   0.00%  $0.00 NASDAQ 8:30a ET
April 22 '24 		Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
     GlobeNewswire
    Full Story →

    Headline News
    Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
    8:30a ET April 10 '24 GlobeNewswire
    Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
    8:30a ET April 2 '24 GlobeNewswire
    Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
    7:00p ET March 1 '24 GlobeNewswire
    More News →
    Day  0.00%Week  26.72%Month  25.9%More Charting →
    April 23 '24. Markets Closed.
    Last $1.70
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $1.70
    Trading volume 1,181
    10 Day avg vol. 15,574,792
    Shares out. 4.1Mil
    Market cap. $6.9Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 23 '24.

    Historical Price Performance
    3 month   37.10% 
    6 month   16.26% 
    1 year   80.95% 
    2 year   95.85% 

    Earnings
    Previous 12m -$5.83
    Next 12m Estimate -$1.99
    P/E ratio 0.3x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.